scholarly journals A CASE OF MID-FREQUENCY SENSORINEURAL HEARING LOSS

2020 ◽  
Vol 18 (Suppl.1) ◽  
pp. 89-92
Author(s):  
At. Vlaykov ◽  
V. Stoyanov
Keyword(s):  
Hearing Loss ◽  
Sensorineural Hearing Loss ◽  
Clinical Case ◽  
Genetic Mutation ◽  
Sensorineural Hearing ◽  
Phone Call ◽  
Long Term Results ◽  
Genetic Origin ◽  
Hereditary Nature

Introduction: Mid-frequency sensorineural hearing loss (MFSNHL) is an unusual audiometric finding with a debatable etiology with unclear long-term results. In general, the middle frequencies are affected first, and the process progresses slowly to include all frequencies. There are also some cases where provocative factors have been reported. Purpose: The aim of the work is to present a clinical case in our practice of the rare occurrence of mid-frequency acoustic hearing loss and its diagnostic approach. Material and methods: The patient has undergone a number of manual and instrumental tests to confirm or reject a specific cause of the hearing loss condition. Results: A 52-year-old man was hospitalised with complaints of hearing loss for about a year, judging by the growing difficulty in making a phone call. Conclusions: Generally, a U-shaped audiogram is thought to indicate hearing loss of genetic origin. However, this type of deafness is not unique to one particular type of genetic mutation. There are also numerous descriptions of non-genetic mid-frequency hearing loss in the literature. In the particular clinical case presented by us, it was concluded that this was a hearing loss, possibly of hereditary nature, after excluding another provocative cause, as well as due to anamnestic data on premature hearing loss in one of the parents.

Long-term results of intratympanic prednisolone injection in patients with idiopathic sudden sensorineural hearing loss

2013 ◽  
Vol 133 (9) ◽  
pp. 900-904 ◽  
Author(s):  
Roberto Filipo ◽  
Giuseppe Attanasio ◽  
Laura Cagnoni ◽  
Eleonora Masci ◽  
Francesca Y. Russo ◽  
...  
Keyword(s):  
Hearing Loss ◽  
Sensorineural Hearing Loss ◽  
Sudden Sensorineural Hearing Loss ◽  
Sensorineural Hearing ◽  
Long Term Results

Long-Term Results of Incus Vibroplasty in Patients with Moderate-to-Severe Sensorineural Hearing Loss

2015 ◽  
Vol 20 (2) ◽  
pp. 136-146 ◽  
Author(s):  
Hannes Maier ◽  
Anna-Lena Hinze ◽  
Timo Gerdes ◽  
Susan Busch ◽  
Rolf Salcher ◽  
...  
Keyword(s):  
Hearing Loss ◽  
Sensorineural Hearing Loss ◽  
Middle Ear ◽  
Speech Intelligibility ◽  
Bone Conduction ◽  
Sensorineural Hearing ◽  
Long Term Results ◽  
Single Subject ◽  
Over Time

Objectives: The principal aim of this study was to assess the safety and effectiveness of the middle ear implant Vibrant Soundbridge (VSB) in patients with moderate-to-severe sensorineural hearing loss up to a mean (± standard deviation) duration of 11.1 ± 2.1 years (min. = 8.2, max. = 13.9, n = 16) after the intervention. Design: This was a retrospective, single-subject repeated-measurements study over a long-term period. A total of 104 German-speaking adults (for 122 implants) were included in this study (54 male, 50 female). The mean age at implantation was 54.5 years (min. = 19.0, max. = 80.4). Audiological outcome and speech intelligibility were assessed in all VSB patients at different time points in non-overlapping groups. Results: Bone conduction (BC) thresholds were preserved after the implantation and no indication was found of an increase over time of the small air-bone gaps introduced by the implantation. BC and air conduction thresholds worsened similarly in both implanted and non-implanted ears over time. The decrease in audiological benefit provided by the VSB was moderate and the Word Recognition Score in quiet conditions at 65 dB SPL was still largely improved with the VSB in the longest observed group. Conclusions: These results confirm that the VSB does not affect the integrity of the inner/middle ear and is still beneficial in long-term follow-up.

scholarly journals Fluctuating Sensorineural Hearing Loss

2019 ◽  
Vol 24 (3) ◽  
pp. 109-116 ◽  
Author(s):  
Hui Liu ◽  
Kunpeng Zhou ◽  
Xuemei Zhang ◽  
Kevin A. Peng
Keyword(s):  
Hearing Loss ◽  
Sensorineural Hearing Loss ◽  
Current Treatment ◽  
Sensorineural Hearing ◽  
Initial Presentation ◽  
Vestibular Aqueduct ◽  
Long Term Follow Up ◽  
Inner Ear Disease ◽  
Fluctuating Hearing Loss

Background: Several otologic conditions can present with fluctuating sensorineural hearing loss, including Ménière’s disease, autoimmune inner ear disease, and enlarged vestibular aqueduct. Although these 3 etiologies vary greatly, distinguishing between these conditions at initial presentation can be challenging. Furthermore, initial treatment of these conditions is often similar. In this review, we discuss historical and current perspectives on diagnosis and treatment of these conditions. Summary: A literature search was performed regarding fluctuating hearing loss, and current treatment of these etiologies of fluctuating hearing loss was summarized. Immediate measures at the onset of acute hearing loss include corticosteroid therapy, while preventative and chronic therapies, which can limit disease severity and frequency, vary based on the specific condition treated. Key Messages: Fluctuating hearing loss can represent a range of pathologies, but the precise etiology may not be clear at initial presentation. Timely treatment and long-term follow-up, along with appropriate diagnostics, are necessary to optimize long-term hearing.

Paediatric revision myringoplasty: outcomes and prospects

2002 ◽  
Vol 116 (9) ◽  
pp. 690-694 ◽  
Author(s):  
Gilead Berger ◽  
Sivan Berger
Keyword(s):  
Hearing Loss ◽  
Sensorineural Hearing Loss ◽  
Acute Otitis Media ◽  
Long Term Results ◽  
Short And Long Term ◽  
Initial Outcome ◽  
Outcome Of Surgery ◽  
Results Of Surgery ◽  
Graft Necrosis

Paediatric revision myringoplasty has received little attention. This study addressed the issue exclusively and reviewed the short- and long-term results of surgery in children between the ages of five and 15. Twenty-six out of 38 operated ears (68.4 per cent) were initially intact. The causes of immediate failure in decreasing order were: infection with graft necrosis, complete no-take of the graft and poor anterior adaptation of the graft. Age, size and site of perforation and surgeon’s experience did not significantly affect the initial outcome of surgery. Six ears developed delayed re-perforations, thus decreasing the overall success rate to 52.6 per cent. The latter were attributable to either episodes of acute otitis media or to insidious atrophy of the tympanic membrane. Notably, none developed post-operative sensorineural hearing loss. It is concluded that the results of paediatric revision myringoplasty are rather disappointing, yet arguments encouraging its practice are favourably presented.

scholarly journals Third-generation bisphosphonates for cochlear otosclerosis stabilizes sensorineural hearing loss in long-term follow-up

2017 ◽  
Vol 2 (5) ◽  
pp. 262-268 ◽  
Author(s):  
Taha A. Jan ◽  
Aaron K. Remenschneider ◽  
Christopher Halpin ◽  
Margaret Seton ◽  
Michael J. McKenna ◽  
...  
Keyword(s):  
Hearing Loss ◽  
Sensorineural Hearing Loss ◽  
Sensorineural Hearing ◽  
Third Generation ◽  
Long Term Follow Up

scholarly journals The Short- and Long-Term Outcome of Intratympanic Steroid Therapy as a Salvage Treatment for Acute Low-Tone Sensorineural Hearing Loss without Episodes of Vertigo

2016 ◽  
Vol 21 (3) ◽  
pp. 132-140 ◽  
Author(s):  
Shinya Morita ◽  
Yuji Nakamaru ◽  
Keishi Fujiwara ◽  
Keiji Iizuka ◽  
Masayori Masuya ◽  
...  
Keyword(s):  
Hearing Loss ◽  
Sensorineural Hearing Loss ◽  
Salvage Treatment ◽  
Sensorineural Hearing ◽  
Control Group ◽  
Long Term Follow Up ◽  
Low Tone ◽  
Hearing Outcomes

Objectives: To evaluate the hearing outcomes of intratympanic steroid (ITS) treatment for patients with acute low-tone sensorineural hearing loss (ALHL) after failure of initial therapy and to investigate the recurrence and progression to definite Ménière's disease (MD) during a long-term follow-up. Methods: We retrospectively reviewed the medical records of 90 patients with refractory ALHL who were followed up for at least 1 year between January 2000 and April 2014. Patients who responded poorly to initial medical treatment received intratympanic dexamethasone injections (ITS group) or isosorbide administration for 4 weeks (diuretic group) as salvage treatment options according to their choice of management. The control group did not receive ITS or the diuretic, due to their refusal of both medical treatments. The hearing outcomes were evaluated 1 month, 1 year and 5 years after the completion of the second-line therapy, and the rates of recurrence and progression to MD were measured during a follow-up period of at least 1 year. Results: Twenty-seven patients in the ITS group, 39 patients in the diuretic group and 24 patients in the control group were enrolled. Of these, 12 patients in the ITS group, 15 patients in the diuretic group and 12 patients in the control group were followed up for over 5 years. We found that the recovery rates and the audiometric functional values after 1 month and 1 year in the ITS group were significantly higher than those in the diuretic and control groups. However, there were no significant differences in the recovery rates or the audiometric functional values after 5 years, or in the rates of recurrence and progression to MD between the groups. Conclusions: Salvage ITS therapy can provide a relatively good short-term hearing outcome for ALHL patients who have persistent hearing loss despite conventional treatment. However, both recurrence and progression to MD after treatment were observed in some patients during the long-term follow-up.

Long-term Incidence and Degree of Sensorineural Hearing Loss in Otosclerosis

2016 ◽  
Vol 37 (10) ◽  
pp. 1489-1496 ◽  
Author(s):  
Reuven Ishai ◽  
Christopher F. Halpin ◽  
Jennifer J. Shin ◽  
Michael J. McKenna ◽  
Alicia M. Quesnel
Keyword(s):  
Hearing Loss ◽  
Sensorineural Hearing Loss ◽  
Sensorineural Hearing
Sign in / Sign up

Export Citation Format

Share Document